Shenzhen Sangel Venture Capital

Shenzhen Sangel Venture Capital (Sangel Capital) is a prominent venture capital firm headquartered in Shenzhen, China, dedicated to the biomedical and healthcare sectors. Established in 2010, it is one of China's earliest professional investment institutions focused on life sciences, managing both RMB and USD funds. The firm specializes in early and growth-stage investments across biotechnology, medical devices, biopharmaceuticals, and digital health. Sangel Capital's portfolio features over 70 innovative companies, including notable names like Sirnaomics, BeyondSpring Pharma, and 3D-Medicines. With a global footprint including offices in Beijing, Suzhou, and Chicago, the firm leverages deep scientific and industry expertise to support transformative medical breakthroughs.